Cardiovascular and hormonal response during a 4-week head-down tilt with and without exercise and LBNP countermeasures.
To determine whether exercise and Lower Body Negative Pressure (LBNP) during 28 days of -6 degrees head-down tilt (HDT) would modify orthostatic tolerance and blood volume regulating hormones, twelve healthy men were assigned to either a no- countermeasure (No-CM, n=6), or a countermeasure (CM, n=6) group.  LBNP sessions consisted of 15 minutes exposure to -30 mm Hg, on days 16, 18, 20 and 22-28 of HDT.  Muscular exercise began on day 8 and consisted of combined graded dynamic and isometric resistance bilateral leg exercise on a specially designed supine ergometer, in two sessions of 15-20 min. each, every day, 6 days per week.  A tilt test was performed before and at the end of HDT.  Changes in resting plasma volume from control day (D-5) to HDT day 24 were -11.2% for No-CM and -2.2% for CM.  After HDT three among the 6 subjects of the No-CM group presented presyncopal or syncopal symptoms, no tilt test was interrupted in CM group.  Atrial Natriuretic Peptide (ANP) decreased at day 7 for the two groups and remained low during all the HDT period for No-CM group only.  Plasma Renin Activity and Aldosterone increased at day 7 and remained elevated for the two groups.  Norepinephrine and epinephrine were unchanged.  Elevated diuresis and natriuresis were evident during the first day of HDT.  However, renal excretory patterns were different between the two groups:  indeed, a decrease of Na+, ANP and cGMP was observed only in No-CM at Day 13 during HDT.  Our data showed that the subjects of the No-CM group experienced a greater increase in heart rate and a decrease in systolic blood pressure during tilt tests after HDT; nevertheless, after HDT, blood pressure was better maintained in CM group during the tilt test.  The plasma volume decrease measured at the end of HDT was significantly lower in CM group, in contrast, these countermeasures were ineffective in preventing at least certain changes in blood volume regulating hormones.
Maillet
A
A
Laboratoire de Physiologie de l'Environnement, France.
Fagette
S
S
Allevard
A M
AM
Pavy-Le Traon
A
A
Guell
A
A
Gharib
C
C
Gauquelin
G
G
D000328:Adult; D000450:Aldosterone / Q000097:blood / Q000378:metabolism; D009320:Atrial Natriuretic Factor / Q000097:blood / Q000378:metabolism; D001510:Bed Rest; D001798:Blood Proteins / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism / Q000652:urine; D003404:Creatinine / Q000097:blood / Q000378:metabolism / Q000652:urine; D004837:Epinephrine / Q000097:blood / Q000378:metabolism; D005081:Exercise Therapy; D018475:Head-Down Tilt / Q000502:physiology*; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007024:Hypotension, Orthostatic / Q000097:blood / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D008150:Lower Body Negative Pressure; D008297:Male; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism; D010953:Plasma Volume / Q000502:physiology; D012083:Renin / Q000097:blood / Q000378:metabolism; D012964:Sodium / Q000097:blood / Q000378:metabolism / Q000652:urine; D018667:Tilt-Table Test; D018544:Weightlessness Countermeasures
D001798:Blood Proteins; D002395:Catecholamines; D000450:Aldosterone; D009320:Atrial Natriuretic Factor; D012964:Sodium; D003404:Creatinine; D012083:Renin; D009638:Norepinephrine; D004837:Epinephrine